Ababei Daniela-Carmen, Balmus Ioana-Miruna, Bild Walther, Ciobica Alin Stelian, Lefter Radu Marian, Rusu Răzvan-Nicolae, Stanciu Gabriela Dumitrita, Cojocaru Sabina, Hancianu Monica, Bild Veronica
Pharmacodynamics and Clinical Pharmacy Department, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.
Advanced Research and Development Center for Experimental Medicine (CEMEX), Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.
Brain Sci. 2023 Aug 16;13(8):1211. doi: 10.3390/brainsci13081211.
As some of the renin-angiotensin-aldosterone system (RAAS)-dependent mechanisms underlying the cognitive performance modulation could include oxidative balance alterations, in this study we aimed to describe some of the potential interactions between RAAS modulators (Losartan and Ramipril) and oxidative stress in a typical model of memory impairment. In this study, 48 white male Swiss mice were divided into six groups and received RAAS modulators (oral administration Ramipril 4 mg/kg, Losartan 20 mg/kg) and a muscarinic receptors inhibitor (intraperitoneal injection scopolamine, 0.5 mg/kg) for 8 consecutive days. Then, 24 h after the last administration, the animals were euthanized and whole blood and brain tissues were collected. Biological samples were then processed, and biochemical analysis was carried out to assess superoxide dismutase and glutathione activities and malondialdehyde concentrations. In the present experimental conditions, we showed that RAAS modulation via the angiotensin-converting enzyme inhibition (Ramipril) and via the angiotensin II receptor blockage (Losartan) chronic treatments could lead to oxidative stress modulation in a non-selective muscarinic receptors blocker (scopolamine) animal model. Our results showed that Losartan could exhibit a significant systemic antioxidant potential partly preventing the negative oxidative effects of scopolamine and a brain antioxidant potential, mainly by inhibiting the oxidative-stress-mediated cellular damage and apoptosis. Ramipril could also minimize the oxidative-mediated damage to the lipid components of brain tissue resulting from scopolamine administration. Both blood serum and brain changes in oxidative stress status were observed following 8-day treatments with Ramipril, Losartan, scopolamine, and combinations. While the serum oxidative stress modulation observed in this study could suggest the potential effect of RAAS modulation and scopolamine administration on the circulatory system, blood vessels endothelia, and arterial tension modulation, the observed brain tissues oxidative stress modulation could lead to important information on the complex interaction between renin-angiotensin and cholinergic systems.
由于认知功能调节背后的一些肾素-血管紧张素-醛固酮系统(RAAS)依赖性机制可能包括氧化平衡改变,在本研究中,我们旨在描述RAAS调节剂(氯沙坦和雷米普利)与氧化应激在典型记忆损伤模型中的一些潜在相互作用。在本研究中,48只雄性瑞士小白鼠被分为六组,连续8天接受RAAS调节剂(口服4 mg/kg雷米普利、20 mg/kg氯沙坦)和一种毒蕈碱受体抑制剂(腹腔注射0.5 mg/kg东莨菪碱)。然后,在最后一次给药后24小时,对动物实施安乐死并采集全血和脑组织。随后对生物样品进行处理,并进行生化分析以评估超氧化物歧化酶和谷胱甘肽活性以及丙二醛浓度。在当前实验条件下,我们表明,通过抑制血管紧张素转换酶(雷米普利)和阻断血管紧张素II受体(氯沙坦)对RAAS进行慢性调节,可在非选择性毒蕈碱受体阻断剂(东莨菪碱)动物模型中导致氧化应激调节。我们的结果表明,氯沙坦可表现出显著的全身抗氧化潜力,部分预防东莨菪碱的负面氧化作用以及脑抗氧化潜力,主要是通过抑制氧化应激介导的细胞损伤和凋亡。雷米普利还可将东莨菪碱给药导致的对脑组织脂质成分的氧化介导损伤降至最低。在用雷米普利、氯沙坦、东莨菪碱及其组合进行8天治疗后,观察到血清和脑氧化应激状态均发生变化。虽然本研究中观察到的血清氧化应激调节可能提示RAAS调节和东莨菪碱给药对循环系统、血管内皮和动脉张力调节的潜在影响,但观察到的脑组织氧化应激调节可能会得出有关肾素-血管紧张素和胆碱能系统之间复杂相互作用的重要信息。